HSBC Initiates Coverage On Moderna with Reduce Rating, Announces Price Target of $97
Portfolio Pulse from richadhand@benzinga.com
HSBC analyst Rajesh Kumar has initiated coverage on Moderna with a Reduce rating and a price target of $97.
July 14, 2023 | 10:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
HSBC has initiated coverage on Moderna with a Reduce rating and a price target of $97, suggesting a potential downside.
The Reduce rating from HSBC indicates a negative outlook for Moderna's stock in the short term. The price target of $97, if lower than the current trading price, suggests that the analyst expects the stock price to decrease.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100